Michael A Marentette

Summary

Affiliation: Merck Research Laboratories
Country: USA

Publications

  1. ncbi Antihypertensive persistence and drug class
    Michael A Marentette
    Merck Frosst Canada Ltd, Kirkland, Canada
    Can J Cardiol 18:649-56. 2002
  2. ncbi Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study
    Rolf J Sebaldt
    Centre for Evaluation of Medicines, St Joseph s Healthcare, McMaster University, Hamilton, Ontario, Canada
    Am J Manag Care 10:742-50. 2004

Collaborators

  • W C Gerth
  • Rolf J Sebaldt
  • Charles H Goldsmith
  • Annie Petrie

Detail Information

Publications2

  1. ncbi Antihypertensive persistence and drug class
    Michael A Marentette
    Merck Frosst Canada Ltd, Kirkland, Canada
    Can J Cardiol 18:649-56. 2002
    ..Noncompliance with antihypertensive therapy is a major problem that hinders successful hypertension management...
  2. ncbi Appropriateness of NSAID and Coxib prescribing for patients with osteoarthritis by primary care physicians in Ontario: results from the CANOAR study
    Rolf J Sebaldt
    Centre for Evaluation of Medicines, St Joseph s Healthcare, McMaster University, Hamilton, Ontario, Canada
    Am J Manag Care 10:742-50. 2004
    ..To assess the appropriateness of nonsteroidal anti-inflammatory drug (NSAID) use relative to recent osteoarthritis treatment guidelines from the Second Canadian Consensus Conference...